A Phase 2a, Randomized, Double-Blind, Placebo Controlled, Multiple Dose Study to Assess the Safety and Tolerability of ASP1941 in Adult Subjects With Type 2 Diabetes Mellitus.
Phase of Trial: Phase II
Latest Information Update: 04 Apr 2018
At a glance
- Drugs Ipragliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Astellas Pharma
- 25 Jun 2010 Results presented at the 70th Annual Scientific Sessions of the American Diabetes Association.
- 03 Mar 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 03 Mar 2009 Actual number of patients (61) added as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History